Carbonic anhydrase inhibitors. Inhibition of the newly isolated murine isozyme XIII with anions

被引:38
作者
Innocenti, A
Lehtonen, JM
Parkkila, S
Scozzafava, A
Supuran, CT
机构
[1] Univ Florence, Lab Chim Bioinorgan, I-50019 Florence, Italy
[2] Tampere Univ, Inst Med Technol, Tampere 33520, Finland
[3] Tampere Univ Hosp, Tampere 33520, Finland
[4] Univ Oulu, Dept Clin Chem, Oulu 90220, Finland
基金
芬兰科学院;
关键词
D O I
10.1016/j.bmcl.2004.07.086
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The inhibition of the newly discovered cytosolic carbonic anhydrase (CA, EC 4.2.1.1) isozyme XIII of murine origin (mCA XIII) has been investigated with a series of anions, such as the physiological ones (bicarbonate, chloride), or the metal complexing anions (cyanate, cyanide, azide, hydrogen sulfide, etc), nitrate, nitrite, sulfate, sulfamate, sulfamide as well as with phenylboronic and phenylarsonic acids. The best mCA XIII inhibitors were cyanate, thiocyanate, cyanide and sulfamide, with K-1-s in the range of 0.25 muM-0.74 mM, whereas fluoride, iodide, azide, carbonate and hydrogen sulfide were less effective (K-1-s in the range of 3.0-5.5 mM). The least effective inhibitors were sulfate, chloride and bicarbonate (K-1-s in the range of 138-267 mM). The affinity of mCA XIII for anions is very different from that of the other cytosolic isozymes (hCA I and II) or the mitochondrial isozyme hCA V. This resistance to inhibition by the physiological anions bicarbonate and chloride suggests an evolutionary adaptation of CA XIII to the presence of high concentrations of such anions (e.g., in the reproductive tract of both female and male), and the possible participation of this isozyme (similarly to CA II, CA IV and CA V) in metabolons with proteins involved in the anion exchange and transport, such as the anion exchangers (AE1-3) or the sodium bicarbonate co-transporter (NBC1 and NBC3) proteins, which remain to be identified. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5435 / 5439
页数:5
相关论文
共 30 条
[1]   Nonaromatic sulfonamide group as an ideal anchor for potent human carbonic anhydrase inhibitors: Role of hydrogen-bonding networks in ligand binding and drug design [J].
Abbate, F ;
Supuran, CT ;
Scozzafava, A ;
Orioli, P ;
Stubbs, MT ;
Klebe, G .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (17) :3583-3587
[2]   Direct extracellular interaction between carbonic anhydrase IV and the human NBC1 sodium/bicarbonate co-transporter [J].
Alvarez, BV ;
Loiselle, FB ;
Supuran, CT ;
Schwartz, GJ ;
Casey, JR .
BIOCHEMISTRY, 2003, 42 (42) :12321-12329
[3]   Carbonic anhydrase inhibitors .37. Novel classes of isozyme I and II inhibitors and their mechanism of action. Kinetic and spectroscopic investigations on native and cobalt-substituted enzymes [J].
Briganti, F ;
Pierattelli, R ;
Scozzafava, A ;
Supuran, CT .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1996, 31 (12) :1001-1010
[4]   Carbonic anhydrase inhibitors: Inhibition of human and murine mitochondrial isozymes V with anions [J].
Franchi, M ;
Vullo, D ;
Gallori, E ;
Antel, J ;
Wurl, M ;
Scozzafava, A ;
Supuran, CT .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (17) :2857-2861
[5]  
Ilies MA, 2004, CRC ENZYM INHIB SER, P209
[6]   Carbonic anhydrase inhibitors.: Inhibition of the zinc and cobalt γ-class enzyme from the archaeon Methanosarcina thermophila with anions [J].
Innocenti, A ;
Zimmerman, S ;
Ferry, JG ;
Scozzafava, A ;
Supuran, CT .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (12) :3327-3331
[7]  
KHALIFAH RG, 1971, J BIOL CHEM, V246, P2561
[8]   C-13 NUCLEAR MAGNETIC-RESONANCE PROBE OF ACTIVE-SITE IONIZATIONS IN HUMAN CARBONIC-ANHYDRASE B [J].
KHALIFAH, RG ;
STRADER, DJ ;
BRYANT, SH ;
GIBSON, SM .
BIOCHEMISTRY, 1977, 16 (10) :2241-2247
[9]   Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family [J].
Lehtonen, J ;
Shen, BR ;
Vihinen, M ;
Casini, A ;
Scozzafava, A ;
Supuran, CT ;
Parkkila, AK ;
Saarnio, J ;
Kivelä, AJ ;
Waheed, A ;
Sly, WS ;
Parkkila, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (04) :2719-2727
[10]   Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design [J].
Lehtonen, JM ;
Parkkila, S ;
Vullo, D ;
Casini, A ;
Scozzafava, A ;
Supuran, CT .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (14) :3757-3762